European Meeting on HIV & Hepatitis 2020

Abstract Book - European Meeting on HIV & Hepatitis 2020

Abstract

HIV

Viral Hepatitis and Liver Disease

Characterization and Resistance Profile of “Unusual” Hepatitis C Virus (HCV) Subtypes in Italy

Abstract

HIV

Viral Hepatitis and Liver Disease

Infection with subtype D adversely affects the live expectancy among people living with HIV – data from Northwestern Poland

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV TRACE vs phylogenetic analysis: unraveling transmission clusters in Spain

Abstract

HIV

Viral Hepatitis and Liver Disease

Prevalence and evolution of transmitted HIV drug resistance in Belgium between 2013 and 2019

Abstract

HIV

Viral Hepatitis and Liver Disease

Factors associated with the emergence of resistance mutations in patients failing dual or triple-integrase inhibitors-based regimen in a French national survey

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV DNA drug resistance genotyping, based on illumina sequencing, as decisional marker for cart opimisation in clinical practice: added value, gaps and future directions

Abstract

HIV

Viral Hepatitis and Liver Disease

High efficacy after switching to integrase strand transfer inhibitors (INSTI) in PLWH with undetectable viremia and past virological failure and/or resistance

Abstract

HIV

Viral Hepatitis and Liver Disease

Emergence and Persistence of Integrase Mutation T97A Selected by Dolutegravir

Abstract

HIV

Viral Hepatitis and Liver Disease

Evaluation of HIV-1 RNA and DNA mutational load in HIV-1 infected heavily treatment-experienced patients harbouring multi-drug resistant strains

Abstract

HIV

Viral Hepatitis and Liver Disease

Long-term Bictegravir and Dolutegravir Resistance Selections Initiated with HIV-1 Containing M184V in Reverse Transcriptase

Abstract

HIV

Viral Hepatitis and Liver Disease

Molecular analysis of HCV subtype 3a dispersal patterns among inmates in Greece: HCV transmissions are not related to incarceration

Abstract

HIV

Viral Hepatitis and Liver Disease

Highly sensitive digital droplet PCR assay allows to reveal cryptic HBV replication in anti-HBc positive/HBsAg negative patients with HIV infection.

Abstract

HIV

Viral Hepatitis and Liver Disease

Susceptibility to HIV-1 integrase inhibitors in HIV-1 sub-subtype A6 isolates

Abstract

HIV

Viral Hepatitis and Liver Disease

Residual phenotypic susceptibility to second generation NNRTI in multidrug resistant HIV-1 from the PRESTIGIO Registry

Abstract

HIV

Viral Hepatitis and Liver Disease

Two-drug regimen (2DR) for initial HIV treatment? – Lessons learned from 20 years RESINA cohort

Abstract

HIV

Viral Hepatitis and Liver Disease

Dynamics of HIV-1 transmission clusters in North and Central Italy over the years 2012-2019

Abstract

HIV

Viral Hepatitis and Liver Disease

Transmitted drug resistance to integrase based first-line HIV antiretroviral treatment in the MeditRes HIV collaboration

Abstract

HIV

Viral Hepatitis and Liver Disease

Exploring Molecular Characteristics and Evolutionary Dynamics of the HIV-1 Epidemic in Montenegro Through Phylogenetic Analyses

Abstract

HIV

Viral Hepatitis and Liver Disease

Prevalence and spatiotemporal dynamics of the HIV-1 circulating recombinant form 03_AB (CRF03_AB) in the former Soviet Union

Abstract

HIV

Viral Hepatitis and Liver Disease

Cabotegravir + Rilpivirine Every 2 Months Is Noninferior to Monthly: ATLAS-2M Study

Abstract

HIV

Viral Hepatitis and Liver Disease

Short- and long-term direct medical costs of late and very late HIV presentation

Abstract

HIV

Viral Hepatitis and Liver Disease

Treatment outcome among people living with HIV starting first-line rapid or GRT guided ART from 2015 to 2018

Abstract

HIV

Viral Hepatitis and Liver Disease

Evaluation of HIV-1 tropism in multidrug-resistant cART failing patients

Abstract

HIV

Viral Hepatitis and Liver Disease

DTG+3TC vs DTG+TDF/FTC (GEMINI1&2): Confirmed Virologic Withdrawals Through Week 96

Abstract

HIV

Viral Hepatitis and Liver Disease

Emergence of Resistance in HIV-1 Integrase following Dolutegravir Treatment in Participants Aged 4 Weeks to <18 Years: Results from the IMPAACT P1093 Study

Abstract

HIV

Viral Hepatitis and Liver Disease

Assessment of Genotypic Patterns Associated with HIV-1 Sensitivity to Ibalizumab

Abstract

HIV

Viral Hepatitis and Liver Disease

In vitro activity of Islatravir against HIV-1 mutants harboring multiple NRTI resistance mutations

Abstract

HIV

Viral Hepatitis and Liver Disease

Detection in HIV proviral DNA of drug resistance mutations in patients with low permanent viral loads

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV-DNA decay in ART-naïve patients starting a DTG-based dual vs triple therapy

Abstract

HIV

Viral Hepatitis and Liver Disease

Role of analytical treatment interruption on HIV peripheral reservoir diversification

Abstract

HIV

Viral Hepatitis and Liver Disease

Similar levels of HIV-DNA and residual viremia are found in virologically suppressed individuals who continue a two-drug regimen with dolutegravir plus one reverse transcriptase inhibitor or switch to EVG/COBI/FTC enrolled in the Be-OnE Study

Abstract

HIV

Viral Hepatitis and Liver Disease

Comprehensive assessment of SARS-CoV-2 key genetic elements single or in clusters underlying geographically-dependent genetic evolutionary adaptation and their impact on drugs binding affinity and immune escape

Abstract

HIV

Viral Hepatitis and Liver Disease

Case report: poor adherence to dolutegravir is associated with selection of resistance mutations T66I, G118R, E138A and L74I

Abstract

HIV

Viral Hepatitis and Liver Disease

Integrase Resistance development after long-term suppressive treatment with Abacavir, Lamivudine and Dolutegravir

Abstract

HIV

Viral Hepatitis and Liver Disease

Difficulty in reaching virological suppression in a long-term treated HIV-1 patient: rather the role of the reservoir than drug resistance?

Abstract

HIV

Viral Hepatitis and Liver Disease

Assessment of quality of life among patients with hepatitis C in Georgia

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV Seronegativity After Rapid ART: A Case Demonstrating Future Challenges in HIV Confirmation Testing in the Era of iART

Abstract

HIV

Viral Hepatitis and Liver Disease

Multicentric Castleman Disease HHV-8 related in a HIV patient

Abstract

HIV

Viral Hepatitis and Liver Disease

Variability in HIV Proviral DNA Genotyping Results from a Single Blood Draw

Abstract

HIV

Viral Hepatitis and Liver Disease

Virological efficacy and resistance evaluation in people living with HIV starting an STR regimen

Abstract

HIV

Viral Hepatitis and Liver Disease

Resistant minority variants observed in failing patients at week 48 in ANRS 170 QUATUOR trial (a 4/7 days maintenance strategy vs a 7/7 days regimen in patients with controlled viral load)

Abstract

HIV

Viral Hepatitis and Liver Disease

Molecular characterization in HCV late relapser patients treated with direct-acting antiviral (DAA) drugs

Abstract

HIV

Viral Hepatitis and Liver Disease

Clinical and virological characteristics and retreatment of patients with chronic hepatitis C virus infection and failure to sofosbuvir, velapatasvir, and voxilaprevir in real-world

Abstract

HIV

Viral Hepatitis and Liver Disease

Pharmaco-virological algorithm to target risk of resistance among a population of HIV-infected female sex workers in Togo

Abstract

HIV

Viral Hepatitis and Liver Disease

Characterization of the NS5A gene of HCV genotype 4 isolates from HIV-1 co-infected patients in a third-level hospital in Mexico

Abstract

HIV

Viral Hepatitis and Liver Disease

Impact of Sexually Transmitted Infections on seminal HIV levels among undetectable patients

Abstract

HIV

Viral Hepatitis and Liver Disease

Bone mineral density in patients with HIV infection and chronic hepatitis C

Abstract

HIV

Viral Hepatitis and Liver Disease

The burden of serious non-AIDS-defining events among admitted cART-naive HIV/AIDS patients in China: An observational cohort study

Abstract

HIV

Viral Hepatitis and Liver Disease

The prevalence of hepatitis B virus seromarkers in patients with HIV/HCV coinfection. An Egyptian cross-sectional study.

Abstract

HIV

Viral Hepatitis and Liver Disease

Seroprevalence and co-infections HIV, HBV and HCV among clinic attenders at Laquintinie Hospital in Douala, Cameroon

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV-DNA from rectal GALT is a valid marker to explore the viral latency

Abstract

HIV

Viral Hepatitis and Liver Disease

The efficacy of first-line therapy based on RPV in HIV-infected patients with pre-existing E138A mutation in reverse transcriptase

Abstract

HIV

Viral Hepatitis and Liver Disease

A Joinpoint Regression Analysis of Trends in HIV Incidence in Balkan Countries in 15 Years Period

Abstract

HIV

Viral Hepatitis and Liver Disease

Using next-generation sequencing to understand the phylogenetics and networks of generalised HIV epidemics in Africa

Abstract

HIV

Viral Hepatitis and Liver Disease

Number, type and cost of microbiological assays during HIV Pre-Exposure Prophylaxis: the experience of a French hospital

Abstract

HIV

Viral Hepatitis and Liver Disease

Breaking bad: Chems, sex and sexual health

Abstract

HIV

Viral Hepatitis and Liver Disease

Using next-generation sequencing to assess the differences in HIV drug resistance pre- and post-treatment in a Treatment as Prevention Trial

Abstract

HIV

Viral Hepatitis and Liver Disease

Knowledge, attitude and practice survey about blood borne infections among Georgian health care workers

Abstract

HIV

Viral Hepatitis and Liver Disease

Determination of drug resistance of hepatitis C virus to NS5A protein inhibitors as a new approach to personalized medicine

Abstract

HIV

Viral Hepatitis and Liver Disease

Next generation sequencing for routine HIV-1 resistance genotyping in a clinical laboratory: unsolved issues

Abstract

HIV

Viral Hepatitis and Liver Disease

Association of viral reservoir with HIV infection duration, viral load and CD4 count

Abstract

HIV

Viral Hepatitis and Liver Disease

Comparison of the Vela Dx Sentosa and in-house MiSeq Next-Generation Sequencing Systems for HIV-1 DNA Genotypic Resistance

Abstract

HIV

Viral Hepatitis and Liver Disease

Creation of an Italian HIV DNA Network for the validation and clinical use of HIV-1 DNA quantification assays

Abstract

HIV

Viral Hepatitis and Liver Disease

Exploratory evaluation for the optimization of next generation sequencing HIV-1 drug resistance outcomes based on an in-house RNA extraction protocol

Abstract

HIV

Viral Hepatitis and Liver Disease

Associations between vitamin D and fibrosis, genotype, viral load in patients having chronic hepatitis C

Abstract

HIV

Viral Hepatitis and Liver Disease

Overview of the national hepatitis B viral load testing programe in Uganda

Abstract

HIV

Viral Hepatitis and Liver Disease

Comparison of the new Alinity m system with the established Abbott RealTime and Hologic Aptima Quant Assay in HIV-1, HCV and HBV viral load measurement including performance and turn-around times

Abstract

HIV

Viral Hepatitis and Liver Disease

The Significance of M2BPGi Marker and CCC DNA in Unknown Etiology Hepatitis

Abstract

HIV

Viral Hepatitis and Liver Disease

A pan-genotypic nearly whole genome amplification approach of HCV by a simple two-step RT-PCR combined with parallel Oxford Nanopore and Illumina sequencing produce highly accurate long-range sequences

Abstract

HIV

Viral Hepatitis and Liver Disease

A hybrid sequencing approach for accurate minority detection and resolving haplotype information

Abstract

HIV

Viral Hepatitis and Liver Disease

The quantification of HBeAg levels differ among the different phases of HBV infection, and can predict therapeutic outcome in the setting of immunosuppression driven HBV reactivation.

Abstract

HIV

Viral Hepatitis and Liver Disease

The effectiveness of the application of serological tests and laboratory indicators as part of RITA for the detection of recent HIV infection

Abstract

HIV

Viral Hepatitis and Liver Disease

Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates

Abstract

HIV

Viral Hepatitis and Liver Disease

TDR surveillance and clinically relevant resistance in Spain: 2019 update

Abstract

HIV

Viral Hepatitis and Liver Disease

Prevalence of drug resistance mutations to rilpivirine and doravirine among NNRTI-experienced patients in Italy

Abstract

HIV

Viral Hepatitis and Liver Disease

HCV resistance associated variants following directly acting agent therapy failure- real life data from Poland

Abstract

HIV

Viral Hepatitis and Liver Disease

Absence of GS-6207 Phenotypic Resistance in HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, and Isolates With Resistance To Existing Drug Classes

Abstract

HIV

Viral Hepatitis and Liver Disease

Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance database

Abstract

HIV

Viral Hepatitis and Liver Disease

Genotyping and treatment issues with unusual 1e and 1g HCV subtypes from African subjects: report of two cases.

Abstract

HIV

Viral Hepatitis and Liver Disease

Susceptibility to bNAbs of transmitted HIV variants among recent infections in France

Abstract

HIV

Viral Hepatitis and Liver Disease

Baseline Hepatitis C Virus NS5A Resistance-Associated Polymorphisms in Patients with and without HIV coinfection in Mexico

Abstract

HIV

Viral Hepatitis and Liver Disease

Substantial clustered transmission of the acute hepatitis C among HIV co-infected men-who-have-sex-with-men (MSM)

Abstract

HIV

Viral Hepatitis and Liver Disease

Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates

Abstract

HIV

Viral Hepatitis and Liver Disease

Antiretroviral resistance in patients with multiple treatment failure in a low-middle income setting

Abstract

HIV

Viral Hepatitis and Liver Disease

Late presentation and HIV drug resistance in patients followed in Portugal between 1984-2017

Abstract

HIV

Viral Hepatitis and Liver Disease

Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected in the Republic of Belarus

Abstract

HIV

Viral Hepatitis and Liver Disease

Genetic characteristic of HIV-1 in patients with treatment failure in Kyrgyzstan in 2017-2018.

Abstract

HIV

Viral Hepatitis and Liver Disease

Case of detection of drug resistance mutations hepatitis C virus to the direct-acting antivirals

Abstract

HIV

Viral Hepatitis and Liver Disease

Prevalence of pretreatment HIV-1 drug resistance among treatment-naïve patients in the Russian Federation, 2014–2018

Abstract

HIV

Viral Hepatitis and Liver Disease

The HBV treatment outcome to cART in HBV/HIV co-Infected patients who failed lamivudine containing regimens

Abstract

HIV

Viral Hepatitis and Liver Disease

Hepatotoxicity and the hepatic panel analysis among HIV-positive Ukrainian patients receiving efaverentz and dolutegravir-containing modes

Abstract

HIV

Viral Hepatitis and Liver Disease

Feasibility and efficacy assessment of hepatitis B vaccination among adult PLWH and vulnerable population in Vinnytsia region, Ukraine

Abstract

HIV

Viral Hepatitis and Liver Disease

Natural course of hepatitis C virus infection: which factors affect spontaneous clearance of HCV among the Ukrainian population?

Abstract

HIV

Viral Hepatitis and Liver Disease

Achieving the goals of the Fast-Track 90-90-90 strategy in the context of an anti-terrorist operation

Abstract

HIV

Viral Hepatitis and Liver Disease

Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1-infected adult patients in German routine clinical practice – 12-month results of the BICSTaR cohort

Abstract

HIV

Viral Hepatitis and Liver Disease

Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results

Abstract

HIV

Viral Hepatitis and Liver Disease

Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action

Abstract

HIV

Viral Hepatitis and Liver Disease

Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH

Abstract

HIV

Viral Hepatitis and Liver Disease

Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients

Abstract

HIV

Viral Hepatitis and Liver Disease

Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability

Abstract

HIV

Viral Hepatitis and Liver Disease

HIV evolution in patients initiating antiretroviral therapy during primary infection

Abstract

HIV

Viral Hepatitis and Liver Disease

Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance

Abstract

HIV

Viral Hepatitis and Liver Disease

A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence

Abstract

HIV

Viral Hepatitis and Liver Disease

Phylogenetic analyses applied to the study of transmission variants in a HIV-1 positive couple

Abstract

HIV

Viral Hepatitis and Liver Disease

Unexpected rising in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.